-
-
Humanized model of the immune system
-
iHuPBMC-T
-
iHuPBMC-NK
-
iHuPBMC-B
-
PBMC-LT
-
CD34+ HSC
-
Winn model
-
iHuPBMC-MHC/KO
-
iHuPBMC-OncVax
-
PBMC mixed inoculation model
more -
-
In vivo tumor experimental platform
-
CDX
-
iHuPDX
-
Non-GLP Toxicology
-
PK/PD
-
Brain in situ model
-
Other in situ models
-
Hematologic tumor model system inoculation
-
Creation of high interstitial tumor models
more -
-
In vitro killing experiment platform
-
Immune co-culture killing model
-
CDC
-
In vitro killing experiment platform
-
IC50
-
PDC High-Throughput In Vitro Pharmacodynamics
-
3D organoids
-
ADCC
-
T cell-mediated killing experiment
more -
-
Mouse-derived immune system model
more -
Tumor vaccine
more -
Cell therapy
more -
In vitro testing platform
more -
Non-GLP Toxicology Platform
more -
Non-tumor model and drug efficacy evaluation platform
-
Systematic Vaccination Model
-
Non-tumor model and drug efficacy evaluation platform
-
Skin injury model
-
Stroke model
-
Liver fibrosis model
-
Diabetes model
-
Gouty Arthritis (GA) Model
-
Pulmonary fibrosis model
-
Systemic lupus erythematosus (SLE) model
-
Inflammatory Bowel Disease (IBD) model
-
Rheumatoid Arthritis (RA) Model
more -
-
-
-
PDX model
-
PDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
CDX model
-
CDX model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Human breast cancer
-
Esophageal cancer in humans
-
Human gastric cancer
-
Colorectal cancer
-
Human liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Human pancreatic cancer
-
Human kidney cancer
-
Human Bladder Cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer in women
-
Human Ovarian Cancer
-
Human skin cancer
-
sarcoma
-
Human Nervous System Cancer
-
Embryonal carcinoma
-
Human Lymphoma
-
Human leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other people
more -
-
Homogeneous Model
-
Homogeneous Model
-
Head and neck cancer
-
Eye cancer
-
Lung cancer
-
Breast cancer
-
Stomach cancer
-
Liver cancer
-
Bile duct cancer
-
Gallbladder cancer
-
Pancreatic cancer
-
Kidney cancer
-
Bladder cancer
-
Ureteral cancer
-
Prostate cancer
-
Uterine cancer
-
Cervical cancer
-
Ovarian cancer
-
Esophageal cancer
-
Skin cancer
-
sarcoma
-
Nervous System Cancer
-
Embryonal carcinoma
-
Lymphoma
-
Leukemia
-
Multiple Myeloma
-
Adrenal gland
-
Mesothelioma
-
Other
-
Colorectal cancer
more -
-
News Center
——
InnoModels Biotechnology: Introduction to the characteristics of dual humanized models
Author:
InnoModels
Release time:
2024-04-24
In the field of biomedical research, animal models have always been an indispensable and important tool. However, traditional animal models often fail to fully simulate human physiological and pathological processes and have certain limitations. In order to solve this problem, InnoModels Biotechnology has launched the Dual Humanized Model. The model is based on human cells and tissues, constructed through advanced bioengineering technology, with a very high degree of simulation and practicability, opening up a new path for biomedical research.
1、High simulation of human physiological and pathological processes
Dual humanized model adopts human cells and tissues, and realizes a high degree of simulation of human physiological and pathological processes through precise gene editing and tissue engineering technology. Such models can not only simulate human tissues and organs in terms of morphology, structure and function, but also simulate the pathogenesis and pathological changes of human diseases. This enables researchers to gain a deeper understanding of the nature and pathogenesis of diseases, providing more accurate and effective guidance for drug development and clinical treatment.
2、Reduce the moral and ethical controversy of animal experiments
Traditional animal models often involve animal experiments, which not only involve moral and ethical controversies, but also may lead to instability and unpredictability of experimental results. The dual humanized model, on the other hand, completely avoids these problems. It uses human cells and tissues without the need for animal experiments, which meets ethical and moral requirements and can provide more accurate and reliable research results.

3、Improve the efficiency of drug development and clinical treatment
The dual humanized model can simulate the pathogenesis and pathological changes of human diseases, providing more accurate and effective guidance for drug development and clinical treatment. By conducting drug screening and efficacy assessment on the model, researchers can screen potential drug candidates faster and conduct in-depth research and optimization on them. This will greatly shorten the drug development cycle and improve the success and efficiency of drug development. At the same time, the dual humanized model can also provide clinicians with more accurate treatment plans, improving treatment effects and patient survival rates.
4、Promote the development of personalized medicine
With the development of gene sequencing and bioinformatics and other technologies, personalized medicine has become an important trend in the field of biomedicine. As a model that highly simulates human physiological and pathological processes, dual humanization model can provide important support for personalized medicine. By constructing dual humanized models with individual differences, researchers can conduct accurate drug screening and efficacy assessment for different individuals' disease characteristics, providing more accurate and effective guidance for personalized medicine.
5. Challenges and prospects
Despite the many advantages and potentials of dual humanized models, they still face some challenges in practical applications. For example, it takes a lot of time and resources to construct models that highly simulate human physiological and pathological processes; at the same time, dual-sourced models may still have some limitations in simulating certain complex diseases. However, with the continuous progress of bioengineering and genomics technologies, it is believed that two-person modeling will be more widely used and developed in the future.
In conclusion, as a model with a high degree of simulation of human physiological and pathological processes, the InnoModels Biotechnology Two-Human Sourcing Model opens up a new path for biomedical research. It not only reduces the moral and ethical controversies of animal experiments and improves the efficiency of drug development and clinical treatment, but also provides important support for the development of personalized medicine. Despite some challenges, it is believed that with the continuous progress of technology and the expansion of application scope, dual humanized models will play a more important role in biomedical research.
InnoModels Biotechnology (Beijing) Co., Ltd.
-
TEL: +86 15711355061
-
E-mail: xuyl@imodels.tech
-
Address: Building 14, No. 79 West Shuangying Road, Changping District, Beijing
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
InnoModels Biotechnology (Beijing) Co., Ltd